POSSIBLE ROLE OF CD22, CD79B AND CD20 EXPRESSION IN DISTINGUISHING SMALL LYMPHOCYTIC LYMPHOMA FROM CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Jovanovic, Danijela [1 ]
Djurdjevic, Predrag [1 ]
Andjelkovic, Nebojsa [1 ]
Zivic, Ljubica [1 ]
机构：
[1] Clin Ctr Kragujevac, Kragujevac, Serbia
来源：
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2012年 / 82B卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：405 / 405
页数：1
相关论文
共 50 条
  • [41] PREVALENCE AND CLINICAL CHARACTERIZATION OF CD20 AND CD22 EXPRESSION IN PEDIATRIC PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Rayburg, Melissa S.
    Marmer, Daniel
    Mo, Jun
    McMasters, Richard
    Smolarek, Teresa
    Lampkin, Beatrice
    Perentesis, John
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 718 - 718
  • [42] Utility of CD200 Expression and CD20 Antibody Binding Capacity in Differentiating Chronic Lymphocytic Leukemia from Other Chronic Lymphoproliferative Disorders
    Naseem, Shano
    Poongodi, R.
    Varma, Neelam
    Malhotra, Pankaj
    Varma, Subhash
    BLOOD, 2015, 126 (23)
  • [43] MOLECULAR MECHANISMS REGULATING CD19, CD20 AND CD22 GENE-EXPRESSION
    KEHRL, JH
    RIVA, A
    WILSON, GL
    THEVENIN, C
    IMMUNOLOGY TODAY, 1994, 15 (09): : 432 - 436
  • [44] High Surface Expression of CD49d (VLA-4) and CD79b Correlates with Acalabrutinib Resistance in Patients with Chronic Lymphocytic Leukemia (CLL)
    Bibikova, Elena
    Law, Brian
    Clevenger, Tracy
    Cheung, Jean
    De Jesus, Gary
    Gulrajani, Michael
    Yamaguchi, Kyoko
    Do, Phuong
    Burke, Kathleen
    Brock, Graham
    Munugalavadla, Veerendra
    Frigault, Melanie M.
    Byrd, John C.
    Furman, Richard R.
    Brown, Jennifer R.
    Covey, Todd
    BLOOD, 2019, 134
  • [45] Expression of Ig-β (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion
    Rassenti, LZ
    Kipps, TJ
    BLOOD, 2000, 95 (08) : 2725 - 2727
  • [46] Association of CD49d expression with small lymphocytic lymphoma (SLL) presentation of chronic lymphocytic leukemia (CLL).
    Strati, Paolo
    Chaffee, Kari G.
    Achenbach, Sara J.
    Slager, Susan L.
    Call, Timothy
    Kay, Neil E.
    Ding, Wei
    Parikh, Sameer Ashok
    Jelinek, Diane F.
    Hanson, Curtis A.
    Shanafelt, Tait D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes
    Yagci, M
    Akar, I
    Sucak, GT
    Haznedar, R
    LEUKEMIA RESEARCH, 2005, 29 (07) : 735 - 738
  • [48] Upregulation of CD20 expression in chronic lymphocytic leukemia (CLL) cells by in vitro exposure to cytokines.
    Venugopal, P
    Sivaraman, S
    Huang, X
    Chopra, HK
    O'Brein, T
    Jajeh, A
    Preisler, HD
    BLOOD, 1998, 92 (10) : 247A - 247A
  • [49] Ofatumumab: A New CD20 Monoclonal Antibody Therapy for B-Cell Chronic Lymphocytic Leukemia
    O'Brien, Susan
    Osterborg, Anders
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (05): : 361 - 368
  • [50] Association between polymorphism of CD20 gene and chronic lymphocytic leukemia in Chinese population
    Fang, Cheng
    Zhu, Dan-Xia
    Wang, Li
    Fan, Lei
    Xu, Ji
    Wu, Jia-Zhu
    Lu, Ting-Xun
    Li, Jian-Yong
    Wu, Chang-Ping
    Xu, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (07): : 11235 - 11243
12345